Most Cases of Hepatitis B Are From Sex. Why Should We Vaccinate Infants?

Researchers from the Centers for Disease Control and Prevention in Atlanta, used data from the Sentinel Counties Study of Viral Hepatitis to examine changes in disease incidence and risk factors for acute hepatitis B during 1982 to 1998.

During this period, the median age of patients with acute hepatitis B increased from 27 years to 32 years, the authors report, while the incidence declined by 76.1% from its peak in 1987.

The report indicates the main risk factors for infection, accounting for more than 88% of cases, were:

• Heterosexual exposure to an infected partner 27.4%,
• Intravenous drug use 18.2%,
• Men having sex with men 13.5%.

During this interval, cases associated with IDU declined by 90.6%, the researchers note, while cases associated with MSM activity fell by 63.5% and with high-risk heterosexual activity by 50.7%.

The new vaccine recommendations to expose infants to this dangerous vaccine just don't make any sense when you consider that nearly 90% of the cases of hepatitis B are from sexual contact.

These recommendations are inexcusable.

There is no possible logical recommendation for this action. All of these arguments are fatally flawed.

Just examine the facts:

The central fact, and the one that helps to explain these insane recommendations, is that the maker of hepatitis B vaccine, Merck, makes one billion dollars a year from this vaccine.

A billion dollars a year goes a long way toward influencing public policy.Who is Behind This?

The group that is pushing this through is called The Hepatitis B coalition. Part of the Immunization Action Coalition, this group was started by a $750,000 grant from the CDC. It is supported by the World Health Organization, World Bank, Rockefeller Foundation and ongoing funding from Smith-Kline, Merck, Aventis and Johnson & Johnson.

What also should be pointed out is that it has been less than three years since the federal government asked the drug companies to take mercury out of this vaccine, and they still haven't complied.

The multi dose hepatitis B vials still contain mercury.

Hepatitis B is about as difficult to catch as AIDS. Namely, you nearly always need to have blood or sexual contact of some sort. That is why the main risk factors are IV drug abusers and those who engage in sex with multiple partners.

Is Hepatitis Vaccine Safe?

The Vaccine Adverse Event Reporting System (VAERS) was developed by the government to report vaccine reactions. Many experts believe that only 10% of the adverse reactions are reported though as reporting is not mandated by law.

Even with only 10% of the problems being reported there were nearly 25,000 VAERS hepatitis B reports from July 1990 to October 31, 1998, showing 439 deaths and 9673 serious reactions involving emergency room visits, hospitalization, disablement or death.

The presence of findings such as brain edema in healthy infants who die very soon after receiving hepatitis B vaccine is profoundly disturbing, especially in view of the frequency of neurological symptoms in the VAERS.

Does this make any sense?

Is Hepatitis B Vaccine Effective in Newborns?

Vaccine derived immunity is thought to be short lived. Between 30-50% of vaccinated individuals lose their antibodies within 7 years.

Up to 60% of persons who initially respond will lose detectable antibodies within 12 years.. So that means that these vaccines will provide little to no protection to the real risks of acquiring hepatitis B, promiscuous sexual behavior and IV drug abuse.

Does this make any sense?

How Many Children Are Hurt or Helped By Hepatitis B Vaccine?

Hepatitis B is a rare, mainly blood-transmitted disease. In 1996 only 54 cases of the disease were reported to the CDC in the 0-1 age group. There were 3.9 million births that year, so the observed incidence of hepatitis B in the 0-1 age group was just 0.001%. In the Vaccine Adverse Event Reporting System (VAERS), there were 1,080 total reports of

adverse reactions from hepatitis B vaccine in 1996 in the 0-1 age group, with 47 deaths reported.

Let us put this in simpler terms. For every child with hepatitis B there were 20 that were reported to have severe complications. Let us also remember that only 10% of the reactions are reported to VAERS, so this means:

Traditional medicine is harming 200 children to protect one from hepatitis B.

Does this make any sense?

How Serious Is a Hepatitis B Infection?

The numbers speak for themselves.

Approximately 50% of patients who contract Hepatitis B develop no symptoms after exposure.

However, the exposure ensures that they will have lifetime immunity. An additional 30% develop only flu-like symptoms, and again, this group will acquire lifetime immunity.

Of the remaining 20% exposed to Hepatitis B will develop the symptoms of the disease. 95% of this 20% will fully recover, with lifetime immunity.

Therefore, less than 5% of people who contract Hepatitis B will become chronic carriers of the infection.

The numbers get even smaller: of that 5%, nearly 75% (or 3.75% of the total exposed) will live with an asymptomatic infection and only 25%, (or only 1.25% of the total number of people exposed) will develop chronic liver disease or liver cancer, 10-30 years after the acute infection. (Hyams, K.C. (1995) Risks of chronicity following acute hepatitis B virus infection: A review. Clin. Infect. Dis. 20, 992-1000.)

Think of that in terms of probability: the possibility of contracting the disease is exceedingly difficult for children and only 1.25% of those that are exposed will actually develop the most serious complication!

This type of a "protecting the needle in the haystack" medicine is absurd at best, dangerous at worst.

Does this make any sense?

How Many Safety Studies Have Been Done On Hepatitis B Vaccine?

None.

A manufacturer's representative was asked in a 1997 Illinois Board of Health hearing to show evidence that the hepatitis B vaccine is safe for a 1-day old infant. The representative stated:

" We have none. Our studies were done on 5- and 10-year-olds."

--The Congressional Quarterly, August 25, 2000, pg. 647

One would think that these would be mandatory, but they are not. All that is required is to show efficacy, (i.e. that the vaccine stimulates an antibody response after it is given), not safety.

In most other industries the fraud represented here would lead to criminal charges.

Does this make any sense?

What Can You Do?

Please tell every pregnant woman you know who about this issue. They need to know the facts BEFORE they are in the hospital and have time to make an informed objective decision. If they are still convinced their child needs hepatitis B vaccine, beg them to make sure their child does not receive the vaccine as a newborn. Delay the vaccine until they really are at a possible risk, like late adolescence.

Only too often drugs that are thought to be safe are pulled from the market after they have killed dozens or hundreds of people. It is hopeful that hepatitis B vaccinations in newborns will be stopped. Medical science will have to recognize the truth sooner or later.

SOURCE: Journal Of Infectious Disease, March 15, 2002;185:713-719Additional Facts